These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2330035

  • 21. The application of the patent laws to the drug approval process.
    Coggio BD, Cerrito FD.
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract] [Full Text] [Related]

  • 22. Swiss patent proposal prompts criticism.
    Burgermeister J.
    Nat Biotechnol; 2004 Oct; 22(10):1323. PubMed ID: 15521096
    [No Abstract] [Full Text] [Related]

  • 23. Biotech patents-business as usual?
    Lawrence S.
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract] [Full Text] [Related]

  • 24. Negotiating the RNAi patent thicket.
    Schmidt C.
    Nat Biotechnol; 2007 Mar; 25(3):273-5. PubMed ID: 17344871
    [No Abstract] [Full Text] [Related]

  • 25. Beyond the letter of the law: the US Federal Circuit interprets section 271(g)(1).
    Tsao R, Hurley EA.
    Nat Biotechnol; 1997 Jan; 15(1):86-7. PubMed ID: 9035112
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Biotech reels over patent ruling.
    Check-Hayden E.
    Nature; 2014 Jul 10; 511(7508):138. PubMed ID: 25008505
    [No Abstract] [Full Text] [Related]

  • 28. India's IP snub.
    Jayaraman KS.
    Nat Biotechnol; 2008 Apr 10; 26(4):362. PubMed ID: 18392000
    [No Abstract] [Full Text] [Related]

  • 29. 'Follow-on biologics': ensuring continued innovation in the biotechnology industry.
    Manheim BS, Granahan P, Dow KJ.
    Health Aff (Millwood); 2006 Apr 10; 25(2):394-404. PubMed ID: 16610097
    [Abstract] [Full Text] [Related]

  • 30. New rulings on the Cetus patent for taq polymerase.
    Leonard DG, Schifreen RS, Sninsky JJ, White TJ.
    Mol Diagn; 2000 Mar 10; 5(1):1-3. PubMed ID: 10837081
    [No Abstract] [Full Text] [Related]

  • 31. Biotechnology products and university-based science.
    Korn D, Heinig SJ.
    JAMA; 2005 Jun 15; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract] [Full Text] [Related]

  • 32. Putting your best mode forward.
    Tsao YR, Tabtiang RK.
    Nat Biotechnol; 2000 Oct 15; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Indirect infringement.
    Becker DM.
    Nat Rev Drug Discov; 2006 Mar 15; 5(3):181. PubMed ID: 16557655
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Patent watch: Diagnostic patents at risk after Federal Circuit decisions.
    Noonan K.
    Nat Rev Drug Discov; 2016 Jun 15; 15(6):377. PubMed ID: 27199249
    [No Abstract] [Full Text] [Related]

  • 37. Protecting rights to early-stage technology.
    Shuster MJ, Su H, Blaug S.
    Nat Biotechnol; 2003 Jun 15; 21(6):701-3. PubMed ID: 12776151
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV.
    Fordham Law Rev; 2008 Apr 15; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract] [Full Text] [Related]

  • 40. Inter Partes Review: Patent Killer No More?
    Chen FC, Lee PS.
    Trends Biotechnol; 2019 Jul 15; 37(7):680-683. PubMed ID: 30890272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.